Closed Loop Neuromodulation
INOPASE
EXPLORING A NEW WAY OF TREATING CHRONIC NEUROLOGICAL DISEASES
THROUGH PERSONALIZED CLOSED-LOOP NEUROMODULATION
With offices in Japan and Australia,
INOPASE empowers and supports people with chronic neurological diseases
to improve their quality of life
Nerve
Stimulation
Nerve
Sensing
Automatic
Adjustment
Neurons
Device
OUR CLOSED-LOOP NEUROMODULATION
Closed-loop neuromodulation is the key to restoring lost function by inducing neuroplasticity in the brain.
Our closed-loop neuromodulation has advanced algorithm to detect symptoms and provide dynamic stimulation therapy.
This innovative technology enables personalized treatment based on biological sensing, unlocking the full potential of your mind and body.
PROJECTS
An integrated solution that promises to revolutionize the way we diagnose and treat challenging diseases.
Closed-Loop
Sacral Neuromodulation
Imagine a breakthrough solution that could ease the burden on those struggling with overactive bladder, while increasing the chances of achieving long-awaited relief.
With the latest advancements in sensing and stimulation technology, we can now offer a path to overactive bladder remission that is both effective and compassionate, helping patients take back control of their lives and achieve the freedom they deserve.
Closed-Loop
Brain Neuromodulation
Imagine a groundbreaking device that has the potential to alleviate the challenges faced by individuals with drug-resistant epilepsy, opening up new possibilities and solutions for them.
By combining cutting-edge sensing and stimulation technology, flexible electrode innovations, and insights of leading clinical experts, we are developing an integrated solution that promises to revolutionize the way we diagnose and treat this challenging condition.
MEMBERS
MUNEMASA SUGIMOTO
Founder & CEO
• 10 years+ business experiences in healthcare industry (Novartis, CDI Medical)
• Project Assistant Professor at the University of Tokyo Hospital
• Japan BIODESIGN Innovation Fellow
• CPA experience (KPMG AZSA LLC.)
• MBA at Washington University in St. Louis, US
WANG YEN PO
Founder & CTO
• 8 years+ experiences in wireless power and closed-loop stimulation development
• Ph.D student in Human Engineer at the University of Tokyo
• Japan BIODESIGN Innovation Fellow
• Fellowship at Innovation for Intelligent World
• BE Health Ventures, Japan PJ Lead
KUMI SAKURAI
CMO
• 15 years+ business and marketing experiences in medical device industry (Medtronic, Abbott, Danaher Corporation)
• Premo Partners, Inc., CEO
• Research Fellow at Keio univ. hospital
• MBA at Kanazawa Institute of Technology, Japan. Master at Waseda University, Japan
ANDREW BATTY
Executive Director Australian Operations
• Experienced MedTech executive and company Director
• Established, managed or raised capital for over 20 private and listed startup companies
• Extensive experience developing and commercialising novel medical devices and biotech for international markets.
• Bachelor of Science and Masters of Commerce
CHRIS ONG
Project Manager of Australian Operations
• Masters of Biomedical engineering University of Melbourne
• Skills in product design and project management.
• Experienced working in a startup enviroment
• Participated in university and SME accelerator programs.
NEWS
2025/05/08
2025/02/21
2024/09/06
2024/09/06
INOPASE has been selected for the JETRO Global Startup Acceleration Program (GSAP): Deep Tech course (Berkeley SkyDeck).
2024/09/06
INOPASE has established a subsidiary, "INOPASE Pty Ltd", in Australia.
2024/09/06
INOPASE has completed a seed funding round.
2024/05/30
2024/05/07
INOPASE has been selected for the Foreign Patent Application Grant Project in 2023 term (Tokyo Metropolitan Small and Medium Enterprise Support Center).
2024/05/07
INOPASE has been selected for the Tokyo Startup Intellectual Property Support Grant Project in 2023 term.
2024/05/07
INOPASE participated in Medtech Spotlight 2024 (Medtech Innovator Asia Pacific 2024 In-Person Pitch Event) held in Singapore from April 16th to 17th, 2024.
NEWS
2025/05/08
2025/02/21
2024/09/06
2024/09/06
INOPASE has been selected for the JETRO Global Startup Acceleration Program (GSAP): Deep Tech course (Berkeley SkyDeck).
2024/09/06
INOPASE has established a subsidiary, "INOPASE Pty Ltd", in Australia.
2024/09/06
INOPASE has completed a seed funding round.
2024/05/30
2024/05/07
INOPASE has been selected for the Foreign Patent Application Grant Project in 2023 term (Tokyo Metropolitan Small and Medium Enterprise Support Center).
2024/05/07
INOPASE has been selected for the Tokyo Startup Intellectual Property Support Grant Project in 2023 term.
2024/05/07
INOPASE participated in Medtech Spotlight 2024 (Medtech Innovator Asia Pacific 2024 In-Person Pitch Event) held in Singapore from April 16th to 17th, 2024.
